Dr Rawal will be responsible for advancing the productivity of the innovation process in the UK and will be the senior medical spokesperson for the ABPI to the Government, the media and other professional bodies.
Stephen Whitehead, ABPI Chief Executive, said the new recruit joins at a “critical time for industry” and said Bina’s experience will “complement that of our members to champion science, discovery, research and development”.
The new innovation lead joins the ABPI from the Wellcome Trust, where she served as Head of Clinical Development within the Technology Transfer Division. Prior to that, Dr Rawal held senior roles at Roche and GlaxoWellcome.
“I am very pleased to be joining the ABPI team and members to lead the campaigns on innovation,” she said. “The pharmaceutical industry plays a vital role as a health care provider in the UK and research and development are an integral part of the patient journey through the NHS.”